ISU302

· ISU Abxis Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ISU302, covering 2013-06-19 to 2017-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease [Phase 3]